Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of High Dose Chemotherapy With Autologous Hematopoietic Progenitor Cell Transplant for Multiple Sclerosis That Failed at Least Two Lines of Therapy

NCT01679041 is registered in ClinicalTrials.gov with Seah Lim M.D. as lead sponsor.

NCT NCT01679041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01679041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of High Dose Chemotherapy With Autologous Hematopoietic Progenitor Cell Transplant for Multiple Sclerosis That Failed at Least Two Lines of Therapy
Lead sponsor
Seah Lim M.D.
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2012
Completion date
November 30, 2013
Enrollment
1 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis